Blog
Focus on Psoriasis: A Report from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV).
Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in…
Read More
Video
TKY2 Inhibitors for the Treatment of Psoriasis.
Dr. Ronald Vender discusses TKY2 Inhibitors and explains their contribution to the initiation and chronicity of…
Watch Video
Blog
World Psoriasis Day 2023: Empowering Access to Timely Treatment and Universal Healthcare from Psoriasis Advocates…
IPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from…
Read More
Video
How to Improve Physician Wellbeing.
Dr. Vender discusses tips to help physicians run a successful clinic while maintaining their mental health and…
Watch Video
Blog
2022 World Psoriasis Day.
The IPC is a proud supporter of World Psoriasis Day by uniting for action with IFPA to advance care and change the…
Read More
Event
Symposium: Innovations in the Pathogenesis and Treatment of Psoriasis.
EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) | BERLIN, GERMANY
Wednesday, October 11
8:30 – 11:45 am…
October 11, 2023
Learn More or Register
Blog
World Psoriasis Day.
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients…
Read More
PDF
Biosimilars for the Treatment of Patients with Psoriasis: A Consensus Statement from the Biosimilar Working Group of…
View Report
PDF
Clinical Goals and Barriers to Effective Psoriasis Care.
View Report
Page
Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology…
The introduction of biological drugs for the treatment of patients with psoriasis has revolutionized treatment…
View Report
Page
Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.
Biosimilars are drugs that are similar, but not identical, to originator biologics. Preclinical analytical studies are…
View Report
Page
Biosimilars for Psoriasis: Preclinical Analytical Assessment to Determine Similarity.
Biosimilars, sometimes called 'generic biologics', are no longer a vision for the future but a present-day reality.…
View Report
